What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients
- PMID: 35326609
- PMCID: PMC8946787
- DOI: 10.3390/cancers14061456
What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients
Abstract
(1) Background: Younger age has been associated with better overall survival (OS) in Ewing sarcoma (ES), especially under the age of 10. The favorable survival in younger patients underlines the need for minimizing treatment burden and late sequelae. Our study aimed at describing clinical characteristics, treatment and outcome of a cohort of ES patients aged 0−10. (2) Methods: In this retrospective multicenter study, all consecutive ES patients aged 0−10, treated in four sarcoma centers in the Netherlands (n = 33) and one in Spain (n = 27) between 1982 and 2008, with a minimum follow-up of 10 years, were included. OS, local recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) were calculated. Potential factors of influence on OS (risk and protective factors) were analyzed. (3) Results: 60 patients with median follow-up 13.03 years were included. All patients were treated with chemotherapy in combination with local treatment, being surgery alone in 30 (50%) patients, radiotherapy (RT) alone in 12 (20%) patients or surgery plus RT in 18 (30%) patients (12 pre- and 6 postoperative). Limb salvage was achieved in 93% of patients. The 10-OS, -LRFS and -DMFS are 81% (95% CI: 71−91%), 89% (95% CI: 85−93%) and 81% (95% CI: 71−91%), respectively. Six patients developed LR, of which two developed subsequent DM; all had axial ES (pelvis, spine or chest wall), and these patients all died. Ten patients developed DM; eight died due to progressive disease, and two are currently in remission, both with pulmonary metastasis only. Negative or wide resection margin was significantly associated with better OS. Age < 6 years, tumor volume < 200 mL, absence of metastatic disease and treatment after 2000 showed trends towards better OS. Two patients developed secondary malignancy; both had chemotherapy combined with definitive RT for local treatment. (4) Conclusions: Overall survival of these youngest patients with ES was very good. Limb salvage surgery was achieved in >90% of patients. Wide resection margin was the only factor significantly associated with better survival.
Keywords: Ewing sarcoma; distant metastasis; local recurrence; long-term outcome; pediatric; secondary malignancy; survival.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.Clin Orthop Relat Res. 2020 Feb;478(2):290-302. doi: 10.1097/CORR.0000000000000962. Clin Orthop Relat Res. 2020. PMID: 31580267 Free PMC article.
-
High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.J Adolesc Young Adult Oncol. 2021 Apr;10(2):185-192. doi: 10.1089/jayao.2020.0016. Epub 2020 Jul 20. J Adolesc Young Adult Oncol. 2021. PMID: 32706630
-
What Is the Success of Repeat Surgical Treatment of a Local Recurrence After Initial Wide Resection of Soft Tissue Sarcomas?Clin Orthop Relat Res. 2018 Sep;476(9):1791-1800. doi: 10.1007/s11999.0000000000000158. Clin Orthop Relat Res. 2018. PMID: 30794216 Free PMC article.
-
Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma.Cancer Manag Res. 2023 Jun 17;15:537-545. doi: 10.2147/CMAR.S362693. eCollection 2023. Cancer Manag Res. 2023. PMID: 37351338 Free PMC article. Review.
-
Outcomes in different age groups with primary Ewing sarcoma of the spine: a systematic review of the literature.J Neurosurg Spine. 2019 Feb 15;30(5):664-673. doi: 10.3171/2018.10.SPINE18795. Print 2019 May 1. J Neurosurg Spine. 2019. PMID: 30771777 Review.
Cited by
-
Does primary tumor resection improve survival for patients with sarcomas of pelvic bones, sacrum, and coccyx who have metastasis at diagnosis ?Eur Spine J. 2023 Dec;32(12):4362-4376. doi: 10.1007/s00586-023-07985-x. Epub 2023 Oct 23. Eur Spine J. 2023. PMID: 37870700
-
Extraosseous Ewing Sarcoma in Children: A Systematic Review and Meta-Analysis of Clinicodemographic Characteristics.Children (Basel). 2022 Nov 29;9(12):1859. doi: 10.3390/children9121859. Children (Basel). 2022. PMID: 36553303 Free PMC article. Review.
-
Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4.Front Oncol. 2024 Oct 8;14:1422605. doi: 10.3389/fonc.2024.1422605. eCollection 2024. Front Oncol. 2024. PMID: 39439958 Free PMC article.
-
Extradural Primary Malignant Spinal Tumors in a Population Younger than 25 Years: An Ambispective International Multicenter Study on Onco-Surgical Outcomes.Cancers (Basel). 2023 Jan 30;15(3):845. doi: 10.3390/cancers15030845. Cancers (Basel). 2023. PMID: 36765803 Free PMC article.
References
-
- Fletcher C.D.M., Hogendoorn P.W.C., Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. IARC; Lyon, France: 2013.
LinkOut - more resources
Full Text Sources